Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases:
Gespeichert in:
Weitere Verfasser: | , , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Cambridge, MA ; San Diego, CA
Academic Press, an imprint of Elsevier
2020
|
Ausgabe: | First edition |
Schriftenreihe: | International review of neurobiology
volume 155 |
Schlagworte: | |
Beschreibung: | xviii, 301 Seiten Illustrationen, Diagramme |
ISBN: | 9780128231210 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV046939197 | ||
003 | DE-604 | ||
005 | 20201106 | ||
007 | t| | ||
008 | 201014s2020 xx a||| |||| 00||| eng d | ||
020 | |a 9780128231210 |c hardback |9 978-0-12-823121-0 | ||
035 | |a (OCoLC)1220899904 | ||
035 | |a (DE-599)BVBBV046939197 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
084 | |a WW 2204 |0 (DE-625)158906:13428 |2 rvk | ||
245 | 1 | 0 | |a Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases |c edited by Grażyna Söderbom (Klipspringer AB, Sävedalen, Sweden), Russell Esterline (AstraZeneca, Gaithersburg MD, United States), Jan Oscarsson (AstraZeneca, Gothenburg, Sweden), Mark P. Mattson (Departement of Neuroscience, John Hopkins University, School of Medicine, Baltimore, MD, United States) |
250 | |a First edition | ||
264 | 1 | |a Cambridge, MA ; San Diego, CA |b Academic Press, an imprint of Elsevier |c 2020 | |
300 | |a xviii, 301 Seiten |b Illustrationen, Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a International review of neurobiology |v volume 155 | |
650 | 0 | 7 | |a Bioenergetik |0 (DE-588)4112769-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Stoffwechsel |0 (DE-588)4057699-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Nervendegeneration |0 (DE-588)4300182-8 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Nervendegeneration |0 (DE-588)4300182-8 |D s |
689 | 0 | 1 | |a Stoffwechsel |0 (DE-588)4057699-1 |D s |
689 | 0 | 2 | |a Bioenergetik |0 (DE-588)4112769-9 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Söderbom, Grażyna |4 edt | |
700 | 1 | |a Esterline, Russell |4 edt | |
700 | 1 | |a Oscarsson, Jan |4 edt | |
700 | 1 | |a Mattson, Mark P. |4 edt | |
830 | 0 | |a International review of neurobiology |v volume 155 |w (DE-604)BV002534817 |9 155 | |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-032347952 |
Datensatz im Suchindex
_version_ | 1817718740085637120 |
---|---|
adam_text | |
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author2 | Söderbom, Grażyna Esterline, Russell Oscarsson, Jan Mattson, Mark P. |
author2_role | edt edt edt edt |
author2_variant | g s gs r e re j o jo m p m mp mpm |
author_facet | Söderbom, Grażyna Esterline, Russell Oscarsson, Jan Mattson, Mark P. |
building | Verbundindex |
bvnumber | BV046939197 |
classification_rvk | WW 2204 |
ctrlnum | (OCoLC)1220899904 (DE-599)BVBBV046939197 |
discipline | Biologie |
discipline_str_mv | Biologie |
edition | First edition |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV046939197</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20201106</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">201014s2020 xx a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128231210</subfield><subfield code="c">hardback</subfield><subfield code="9">978-0-12-823121-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1220899904</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046939197</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WW 2204</subfield><subfield code="0">(DE-625)158906:13428</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases</subfield><subfield code="c">edited by Grażyna Söderbom (Klipspringer AB, Sävedalen, Sweden), Russell Esterline (AstraZeneca, Gaithersburg MD, United States), Jan Oscarsson (AstraZeneca, Gothenburg, Sweden), Mark P. Mattson (Departement of Neuroscience, John Hopkins University, School of Medicine, Baltimore, MD, United States)</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">First edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, MA ; San Diego, CA</subfield><subfield code="b">Academic Press, an imprint of Elsevier</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xviii, 301 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">International review of neurobiology</subfield><subfield code="v">volume 155</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bioenergetik</subfield><subfield code="0">(DE-588)4112769-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Stoffwechsel</subfield><subfield code="0">(DE-588)4057699-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nervendegeneration</subfield><subfield code="0">(DE-588)4300182-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Nervendegeneration</subfield><subfield code="0">(DE-588)4300182-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Stoffwechsel</subfield><subfield code="0">(DE-588)4057699-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Bioenergetik</subfield><subfield code="0">(DE-588)4112769-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Söderbom, Grażyna</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Esterline, Russell</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oscarsson, Jan</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mattson, Mark P.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">International review of neurobiology</subfield><subfield code="v">volume 155</subfield><subfield code="w">(DE-604)BV002534817</subfield><subfield code="9">155</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032347952</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV046939197 |
illustrated | Illustrated |
index_date | 2024-07-03T15:37:28Z |
indexdate | 2024-12-06T19:01:16Z |
institution | BVB |
isbn | 9780128231210 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032347952 |
oclc_num | 1220899904 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | xviii, 301 Seiten Illustrationen, Diagramme |
publishDate | 2020 |
publishDateSearch | 2020 |
publishDateSort | 2020 |
publisher | Academic Press, an imprint of Elsevier |
record_format | marc |
series | International review of neurobiology |
series2 | International review of neurobiology |
spelling | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases edited by Grażyna Söderbom (Klipspringer AB, Sävedalen, Sweden), Russell Esterline (AstraZeneca, Gaithersburg MD, United States), Jan Oscarsson (AstraZeneca, Gothenburg, Sweden), Mark P. Mattson (Departement of Neuroscience, John Hopkins University, School of Medicine, Baltimore, MD, United States) First edition Cambridge, MA ; San Diego, CA Academic Press, an imprint of Elsevier 2020 xviii, 301 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier International review of neurobiology volume 155 Bioenergetik (DE-588)4112769-9 gnd rswk-swf Stoffwechsel (DE-588)4057699-1 gnd rswk-swf Nervendegeneration (DE-588)4300182-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Nervendegeneration (DE-588)4300182-8 s Stoffwechsel (DE-588)4057699-1 s Bioenergetik (DE-588)4112769-9 s DE-604 Söderbom, Grażyna edt Esterline, Russell edt Oscarsson, Jan edt Mattson, Mark P. edt International review of neurobiology volume 155 (DE-604)BV002534817 155 |
spellingShingle | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases International review of neurobiology Bioenergetik (DE-588)4112769-9 gnd Stoffwechsel (DE-588)4057699-1 gnd Nervendegeneration (DE-588)4300182-8 gnd |
subject_GND | (DE-588)4112769-9 (DE-588)4057699-1 (DE-588)4300182-8 (DE-588)4143413-4 |
title | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases |
title_auth | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases |
title_exact_search | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases |
title_exact_search_txtP | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases |
title_full | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases edited by Grażyna Söderbom (Klipspringer AB, Sävedalen, Sweden), Russell Esterline (AstraZeneca, Gaithersburg MD, United States), Jan Oscarsson (AstraZeneca, Gothenburg, Sweden), Mark P. Mattson (Departement of Neuroscience, John Hopkins University, School of Medicine, Baltimore, MD, United States) |
title_fullStr | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases edited by Grażyna Söderbom (Klipspringer AB, Sävedalen, Sweden), Russell Esterline (AstraZeneca, Gaithersburg MD, United States), Jan Oscarsson (AstraZeneca, Gothenburg, Sweden), Mark P. Mattson (Departement of Neuroscience, John Hopkins University, School of Medicine, Baltimore, MD, United States) |
title_full_unstemmed | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases edited by Grażyna Söderbom (Klipspringer AB, Sävedalen, Sweden), Russell Esterline (AstraZeneca, Gaithersburg MD, United States), Jan Oscarsson (AstraZeneca, Gothenburg, Sweden), Mark P. Mattson (Departement of Neuroscience, John Hopkins University, School of Medicine, Baltimore, MD, United States) |
title_short | Metabolic and bioenergetic drivers of neurodegenerative disease: Treating neurodegenerative diseases as metabolic diseases |
title_sort | metabolic and bioenergetic drivers of neurodegenerative disease treating neurodegenerative diseases as metabolic diseases |
topic | Bioenergetik (DE-588)4112769-9 gnd Stoffwechsel (DE-588)4057699-1 gnd Nervendegeneration (DE-588)4300182-8 gnd |
topic_facet | Bioenergetik Stoffwechsel Nervendegeneration Aufsatzsammlung |
volume_link | (DE-604)BV002534817 |
work_keys_str_mv | AT soderbomgrazyna metabolicandbioenergeticdriversofneurodegenerativediseasetreatingneurodegenerativediseasesasmetabolicdiseases AT esterlinerussell metabolicandbioenergeticdriversofneurodegenerativediseasetreatingneurodegenerativediseasesasmetabolicdiseases AT oscarssonjan metabolicandbioenergeticdriversofneurodegenerativediseasetreatingneurodegenerativediseasesasmetabolicdiseases AT mattsonmarkp metabolicandbioenergeticdriversofneurodegenerativediseasetreatingneurodegenerativediseasesasmetabolicdiseases |